Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome. Mostafa MA, Zand M, Taylor J, Kouides P, et al. Am J Hematol 2024;99:2241-2243.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mostafa MA, Zand M, Taylor J, Kouides P, et al. Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome. Am J Hematol 2024;99:2241-2243.
PMID: 39177420